BIO vs CPBI · rev $651.0M vs P/E 18, rev $27.7M
BIO (BIO) versus Central Plains Bancshares, Inc. Common Stock (CPBI) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Central Plains Bancshares, Inc. Common Stock (CPBI) is a banks - regional company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported CPBI revenue for 2026-03-31 was $27.7M. Net income was $4.0M. Revenue was up 12.0% from 2025-03-31 to 2026-03-31. CPBI currently screens at market cap $77.8M and trailing P/E 18.0.
BIO currently screens at market cap $0. CPBI currently screens at market cap $77.8M and trailing P/E 18.0.
Not investment advice. Open the BIO and CPBI stock pages for the full models.
Not investment advice.